Law360, New York (April 09, 2012, 6:52 PM ET) -- A Columbia University medical school professor received at least $150,000 from Merck & Co. before testifying for the drug company in a woman's suit claiming the osteoporosis drug Fosamax caused her jaw deterioration, the plaintiff's lawyer alleged in state court Monday.
Plaintiffs lawyer Timothy O'Brien spent hours during a New Jersey state court trial on Monday questioning Merck expert John Bilezikian, asking him to confirm that he had received between $150,000 and $200,000 from the company over 15 years and whether he helped Merck market its...
Fosamax Expert Grilled Over Financial Ties To Merck
To view the full article, take a free trial now.
